ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project
Jazyk angličtina Země Dánsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
Grantová podpora
RNSA - International
Fondation FMC VIA-LR, RNSA - International
European Union Development and Structural Funds - International
PubMed
30565275
DOI
10.1111/all.13701
Knihovny.cz E-zdroje
- Klíčová slova
- Allergic Rhinitis and its Impact on Asthma, Asthma, Care pathways, Pharmacist, Rhinitis,
- MeSH
- adherence k farmakoterapii MeSH
- alergická rýma diagnóza farmakoterapie epidemiologie imunologie MeSH
- farmaceuti MeSH
- kritické cesty * MeSH
- lékárny * MeSH
- lidé MeSH
- management nemoci MeSH
- ochrana veřejného zdraví MeSH
- role odborníka MeSH
- systémy pro podporu klinického rozhodování MeSH
- telemedicína MeSH
- určení symptomu MeSH
- veřejné zdravotnické služby * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Pharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care.
Allergy and Asthma Associates of Southern California Mission Viejo California
Allergy and Clinical Immunology Department Centro Médico Docente la Trinidad Caracas Trinidad
Allergy Center CUF Descobertas Hospital Lisbon Portugal
Association of Finnish Pharmacies Helsinki Finland
Biomax Informatics AG Munich Germany
Center for Rhinology and Allergology Wiesbaden Germany
Centre for Clinical Research Sörmland Uppsala University Eskilstuna Sweden
Centre for Empowering Patients and Communities Faulkland Somerset UK
Children's Hospital Srebrnjak Zagreb School of Medicine University J J Strossmayer Osijek Croatia
CIBER Epidemiología y Salud Pública Barcelona Spain
CIRFF Federico 2 University Naples Italy
Clínica El Avila Altamira Caracas Venezuela
CRI Clinical Research International Ltd Hamburg Germany
Danish Committee for Health Education Copenhagen East Denmark
Department of Allergy and Clinical Immunology Ajou University School of Medicine Suwon South Korea
Department of Allergy and Immunology Hospital Quirón Bizkaia Erandio Spain
Department of Clinical Pharmacy of Lithuanian University of Health Sciences Kaunas Lithuania
Department of ENT Medical University of Graz Graz Austria
Department of Immunology Monash University Melbourne Victoria Australia
Department of Internal Medicine Medical University of Graz Graz Austria
Department of Medicine Bon Secours Hospital Glasnevin Dublin Ireland
Department of Medicine Clinical Immunology and Allergy McMaster University Hamilton Ontario Canada
Department of Nephrology and Endocrinology Karolinska University Hospital Stockholm Sweden
Department of Otolaryngology Nippon Medical School Tokyo Japan
Department of Otorhinolaryngology Academic Medical Centre Amsterdam The Netherlands
Department of Otorhinolaryngology Chiba University Hospital Chiba Japan
Department of Otorhinolaryngology Universitätsklinikum Düsseldorf Dusseldorf Germany
Department of Otorhinolaryngology University of Crete School of Medicine Heraklion Greece
Department of Paediatrics Oslo University Hospital Oslo Norway
Department of Pediatrics Hospital Archbishop Makarios 3 Nicosia Cyprus
Department of Pediatrics Nippon Medical School Tokyo Japan
Department of Pharmacy of University of Naples Federico 2 Naples Italy
Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands
Department of Pulmonary Medicine Rashid Hospital Dubai UAE
Department of Pulmonology Celal Bayar University Manisa Turkey
Department of Respiratory Diseases Montpellier University Hospital Montpellier France
DG for Health and Social Care Scottish Government Edinburgh UK
Division of Allergy Asthma and Clinical Immunology Emek Medical Center Afula Israel
Division of Allergy Immunology University of South Florida Tampa Florida
EFA European Federation of Allergy and Airways Diseases Patients' Associations Brussels Belgium
EIP AHA Reference Site Coimbra Portugal
ENT Department University Hospital of Kinshasa Kinshasa Congo
Eshelman School of Pharmacy University of North Carolina Chapel Hill North Carolina
European Academy of Paediatrics Brussels Belgium
European Health Futures Forum Isle of Wright UK
Faculty of Medicine Institute of Clinical Medicine University of Oslo Oslo Norway
Faculty of Medicine University of Coimbra Coimbra Portugal
Faculty of Medicine Vilnius University Vilnius Lithuania
Farmacias Holon Lisbon Portugal
Farmacie Dei Golfi Group Massa Lubrense Italy
GARD Chairman Geneva Switzerland
Hospital of the Hospitaller Brothers in Buda Budapest Hungary
ICVS 3B's PT Government Associate Laboratory Braga Guimarães Portugal
Immunology and Allergy Division Clinical Hospital University of Chile Santiago Chile
Imunoalergologia Centro Hospitalar Universitário de Coimbra Coimbra Portugal
Institute for Clinical Epidemiology and Biometry University of Wuerzburg Wuerzburg Germany
iQ4U Consultants Ltd London UK
ISGlobAL Centre for Research in Environmental Epidemiology Barcelona Spain
Johns Hopkins School of Medicine Baltimore Maryland
KYomed INNOV Montpellier France
Laboratory of Clinical Immunology Department of Microbiology and Immunology KU Leuven Leuven Belgium
Life and Health Sciences Research Institute School of Medicine University of Minho Braga Portugal
MACVIA France Fondation Partenariale FMC VIA LR Montpellier France
Medical Consulting Czarlewski Levallois France
MedScript Ltd Dundalk Co Louth Ireland
National Hospital Organization Tokyo National Hospital Tokyo Japan
Nova Southeastern University Fort Lauderdale Florida
Pediatric Allergy and Immunology Unit Children's Hospital Ain Shams University Cairo Egypt
Pharmacist Municipality Pharmacy Sarno Italy
ProAR Nucleo de Excelencia em Asma Federal University of Bahia Bahia Brazil
Section of Allergy and Immunology Saint Louis University School of Medicine Saint Louis Missouri
Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires Argentina
Skin and Allergy Hospital Helsinki University Hospital Helsinki Finland
Sociedad Paraguaya de Alergia Asma e Inmunologie Asuncion Paraguay
The Allergy and Asthma Institute Islamabad Pakistan
Transylvania University Brasov Brasov Romania
Ukrainian Medical Stomatological Academy Poltava Ukraine
Unit of Geriatric Immunoallergology University of Bari Medical School Bari Italy
Universidad Católica de Córdoba Córdoba Argentina
Universitat Pompeu Fabra Barcelona Spain
Université Versailles St Quentin en Yvelines UMR S 1168 Montigny le Bretonneux France
University Clinic of Respiratory and Allergic Diseases Golnik Slovenia
University Hospital 'Sv Ivan Rilski' Sofia Bulgaria
University Hospital Montpellier France
University of Helsinki Helsinki Finland
University of Medicine and Pharmacy Hochiminh City Vietnam
Upper Airways Research Laboratory ENT Department Ghent University Hospital Ghent Belgium
Citace poskytuje Crossref.org